Internal Innovation; Active In-Licensing.

Appili Therapeutics is proud to be at the forefront of global efforts to address serious infectious disease threats.

Our systematic approach to building a diverse pipeline provides investment opportunities that serve the needs of patients, payers, and clinicians. Our strategy centers on identifying unmet medical needs, rather than adhering to a specific platform or technology, and matching those needs with potential solutions in the marketplace. This approach provides financial stability and the opportunity to leverage a broad range of government and industry programs, as well as to develop transformative programs that can impact the fundamental treatment landscape for many types of infections.

Latest News


VIDEO: Appili Therapeutics is well funded and working to combat infectious diseases

September 26, 2019
Appili Therapeutics Announces Voting Results of Annual and Special Meeting of Shareholders
September 16, 2019
Appili Therapeutics Retains BND Projects for Strategic Investor Relations Services
August 21, 2019
Appili Therapeutics Reports Financial Results for First Quarter of Fiscal Year 2020